Cargando…

Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma

PTEN is one of the most frequently altered tumor suppressor genes in malignant tumors. The dominant-negative effect of PTEN alteration suggests that the aberrant function of PTEN mutation might be more disastrous than deletion, the most frequent genomic event in glioblastoma (GBM). This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Seung Won, Lee, Yeri, Shin, Kayoung, Koo, Harim, Kim, Donggeon, Sa, Jason K., Cho, Hee Jin, Shin, Hye-mi, Lee, Se Jeong, Kim, Hyunho, Chung, Seok, Shin, Jihye, Lee, Cheolju, Nam, Do-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027895/ https://www.ncbi.nlm.nih.gov/pubmed/33828082 http://dx.doi.org/10.1038/s41419-021-03657-0

Ejemplares similares

PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma
por: Shin, Yong Jae, et al.
Publicado: (2019)

Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening
por: Shin, Kayoung, et al.
Publicado: (2020)

Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models
por: Lee, Mijeong, et al.
Publicado: (2019)

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts
por: Lee, Kyoungmin, et al.
Publicado: (2020)

FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2
por: Lee, Yeri, et al.
Publicado: (2015)

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma
por: Choi, Seung Won, et al.
Publicado: (2018)

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
por: Nam, Yoonhee, et al.
Publicado: (2023)

Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts
por: Lee, Hye Won, et al.
Publicado: (2019)

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
por: Sa, Jason K., et al.
Publicado: (2020)

Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
por: Lim, Sungsu, et al.
Publicado: (2018)

Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2019)

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2020)

Ethnic delineation of primary glioblastoma genome
por: Koo, Harim, et al.
Publicado: (2020)

Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance
por: Choi, Seung Won, et al.
Publicado: (2020)

Use of Composite Protein Database including Search Result Sequences for Mass Spectrometric Analysis of Cell Secretome
por: Shin, Jihye, et al.
Publicado: (2015)

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
por: Lee, Jaehyun, et al.
Publicado: (2018)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes
por: Shin, Jihye, et al.
Publicado: (2016)

Comparative analysis of differentially secreted proteins in serum-free and serum-containing media by using BONCAT and pulsed SILAC
por: Shin, Jihye, et al.
Publicado: (2019)

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
por: Oh, Sejin, et al.
Publicado: (2020)

Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function
por: Jeon, Sohee, et al.
Publicado: (2017)

Ly6G(+) inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model
por: Jeon, Hee-Young, et al.
Publicado: (2019)

PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells
por: Shin, Jin Woo, et al.
Publicado: (2021)

Isolation of a polyethylene-degrading bacterium, Acinetobacter guillouiae, using a novel screening method based on a redox indicator
por: Kim, Hong Rae, et al.
Publicado: (2023)

Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019)

Ultrasound diagnosis and treatment of intractable anterior chest pain from golf - A case report –
por: Park, Jihye, et al.
Publicado: (2023)

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
por: Park, Hyunkyu, et al.
Publicado: (2017)

Nasal Turbinate Mesenchymal Stromal Cells Preserve Characteristics of Their Neural Crest Origin and Exert Distinct Paracrine Activity
por: Kim, Hyun-Jee, et al.
Publicado: (2021)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Antisense Oligonucleotides against Let-7 Enhance the Therapeutic Potential of Mesenchymal Stromal Cells
por: Lee, Dae-Won, et al.
Publicado: (2023)

The relationship between sitting balance, trunk control and mobility with predictive for current mobility level in survivors of sub-acute stroke
por: Lee, Kyeongbong, et al.
Publicado: (2021)

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
por: Her, Nam-Gu, et al.
Publicado: (2018)

Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma
por: Kim, Kyu-Tae, et al.
Publicado: (2016)

PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
por: Lee, Min-Sik, et al.
Publicado: (2015)

iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
por: Lee, Hae-Ri, et al.
Publicado: (2023)

Quantitative radiomic profiling of glioblastoma represents transcriptomic expression
por: Kong, Doo-Sik, et al.
Publicado: (2018)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015)

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Park, Se Jun, et al.
Publicado: (2021)

Distinction of Male and Female Trees of Ginkgo biloba Using LAMP
por: Lee, Jin-Pyo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_img1n5b1am4alr1dfgg2g01oau